Relief of Hypochromic Anemia in Dogs with Synthetic Vitamin B6: Influence of "Filtrate Factors."

1940 ◽  
Vol 43 (3) ◽  
pp. 429-432 ◽  
Author(s):  
H. J. Borson ◽  
S. R. Mettier
1940 ◽  
Vol 43 (4) ◽  
pp. 660-663 ◽  
Author(s):  
S. G. Smith ◽  
D. W. Martin
Keyword(s):  

Nature ◽  
1940 ◽  
Vol 145 (3671) ◽  
pp. 388-388 ◽  
Author(s):  
R. W. VILTER ◽  
H. S. SCHIRO ◽  
T. D. SPIES

1982 ◽  
Vol 1 (2) ◽  
pp. 78-84 ◽  
Author(s):  
Barbara Pickard

A vitamin B6 deficiency develops during pregnancy and contributing factors include: a disturbance in vitamin B6 metabolism caused by increasing levels of oestrogens; increasing fetal demand for vitamin B6; a disturbance in vitamin B6 status caused by oral contraceptive usage prior to conception; a deficient intake of vitamin B6. Hormonal changes and increasing fetal requirements impose considerable stress on maternal vitamin B6 status but are the inevitable consequences of pregnancy. In contrast, longterm use of oral contraceptives before pregnancy and an inadequate vitamin B6 intake, both prior to and during pregnancy, are potentially avoidable. Dietary intakes of vitamin B6 in many women fall well below the recommended 1.5–2.0mg/day before pregnancy and 2.5mg/day during pregnancy. Although supplementation with synthetic vitamin B6 is advocated by many, much greater emphasis should also be placed on a wholesome, healthy diet. Examples are given of foods high and low in vitamin B6 and of a daily diet providing 2.5mg of vitamin B6.


Science ◽  
1939 ◽  
Vol 89 (2311) ◽  
pp. 347-347 ◽  
Author(s):  
S. A. Harris ◽  
K. Folkers
Keyword(s):  

1938 ◽  
Vol 16 (2) ◽  
pp. 197-207 ◽  
Author(s):  
Paul J. Fouts ◽  
O. M. Helmer ◽  
S. Lepkovsky ◽  
T. H. Jukes

Blood ◽  
1961 ◽  
Vol 17 (5) ◽  
pp. 547-561 ◽  
Author(s):  
LUIS SANCHEZ MEDAL ◽  
JORGE ELIZONDO ◽  
JESUS TORRES GALLARDO ◽  
CARLOS GITTLER

Abstract The clinical and laboratory findings in two brothers with severe anemia are presented. These findings were very similar in both cases. Evidence that at least one of them suffered from a pyridoxine-responsive anemia is presented. It was assumed that the other had the same disorder since, in addition to the striking similarity in the clinical and laboratory abnormalities, the latter’s anemia disappeared completely with the parenteral administration of vitamin B complex, which provided him with 2 mg. of pyridoxine daily. These patients have not relapsed 1.5 and 6 years after stopping the therapy. A review of the reported cases with anemia responding to vitamin B6 administration is presented. Common factors observed in some of these cases are: (1) severe anemia, microcytic and hypochromic in type, chiefly due to a striking maturation erythroblastic arrest at the basophilic stage with no defect in leukocytes or thrombocytes; (2) hyperferremia and hemosiderosis; (3) an abnormal tryptophan-loading test; and (4) complete or almost complete correction of all abnormalities with administration of vitamin B6, even at small doses. These data were considered to suggest that the patients had a true deficiency in pyridoxine. In other patients, no increased excretion of xanthurenic acid has been observed after a tryptophan-loading dose, and pyridoxine administration has improved the anemia only partially and has not reversed the serum iron parameters to normality. All of these other patients suffered from a familial hypochromic anemia not due to iron deficiency or from a "sidero-achrestic" or "refractory normoblastic" anemia. The cause of the disorder in patients in the first group is unknown, but, by exclusion, increased requirement of vitamin B6 seems to be the most likely possibility.


Blood ◽  
1962 ◽  
Vol 19 (3) ◽  
pp. 304-312 ◽  
Author(s):  
JOHN N. BICKERS ◽  
CHARLES L. BROWN ◽  
CHARLES C. SPRAGUE ◽  
Katherine Karst

Abstract A patient is reported with pyridoxine responsive anemia superimposed upon a chronic hypochromic anemia with excess iron storage. A specific response to pyridoxine was demonstrated on several occasions with restoration of the blood picture to its original state. Dietary estimates of vitamin B6 intake demonstrated an increased requirement for the vitamin, approximately 2.5 mg. per day being required for hematologic remission. Splenectomy was followed by high circulating siderocyte levels and severe thromboembolic problems. The possible mechanisms for the development of pyridoxine responsive anemia are discussed briefly.


2020 ◽  
Vol 4 (9) ◽  
pp. 46-59
Author(s):  
Adriatico Aileen ◽  
Garcia Victor ◽  
Vega Huerta Salvador ◽  
Conway Michelle ◽  
Tawil Bill

Author(s):  
V.J. Montpetit ◽  
S. Dancea ◽  
L. Tryphonas ◽  
D.F. Clapin

Very large doses of pyridoxine (vitamin B6) are neurotoxic in humans, selectively affecting the peripheral sensory nerves. We have undertaken a study of the morphological and biochemical aspects of pyridoxine neurotoxicity in an animal model system. Early morphological changes in dorsal root ganglia (DRG) associated with pyridoxine megadoses include proliferation of neurofilaments, ribosomes, rough endoplasmic reticulum, and Golgi complexes. We present in this report evidence of the formation of unique aggregates of microtubules and membranes in the proximal processes of DRG which are induced by high levels of pyridoxine.


Sign in / Sign up

Export Citation Format

Share Document